Literature DB >> 25645334

Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells.

Qian Liu1, Shanquan Sun, Wei Yu, Jin Jiang, Fei Zhuo, Guoping Qiu, Shiye Xu, Xuli Jiang.   

Abstract

Long non-coding RNAs (lncRNAs), a recently discovered class of non-coding genes, are transcribed throughout the genome. Emerging evidence suggests that lncRNAs may be involved in modulating various aspects of tumor biology, including regulating gene activity in response to external stimuli or DNA damage. No data are available regarding the expression of lncRNAs during genotoxic stress-induced apoptosis and/or necrosis in human glioma cells. In this study, we detected a change in the expression of specific candidate lncRNAs (neat1, GAS5, TUG1, BC200, Malat1, MEG3, MIR155HG, PAR5, and ST7OT1) during DNA damage-induced apoptosis in human glioma cell lines (U251 and U87) using doxorubicin (DOX) and resveratrol (RES). We also detected the expression pattern of these lncRNAs in human glioma cell lines under necrosis induced using an increased dose of DOX. Our results reveal that the lncRNA expression patterns are distinct between genotoxic stress-induced apoptosis and necrosis in human glioma cells. The sets of lncRNA expressed during genotoxic stress-induced apoptosis were DNA-damaging agent-specific. Generally, MEG3 and ST7OT1 are up-regulated in both cell lines under apoptosis induced using both agents. The induction of GAS5 is only clearly detected during DOX-induced apoptosis, whereas the up-regulation of neat1 and MIR155HG is only found during RES-induced apoptosis in both cell lines. However, TUG1, BC200 and MIR155HG are down regulated when necrosis is induced using a high dose of DOX in both cell lines. In conclusion, our findings suggest that the distinct regulation of lncRNAs may possibly involve in the process of cellular defense against genotoxic agents.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645334     DOI: 10.1007/s11060-015-1718-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

Review 1.  Non-coding RNAs: Meet thy masters.

Authors:  Fabrício F Costa
Journal:  Bioessays       Date:  2010-07       Impact factor: 4.345

2.  Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.

Authors:  Pengjun Wang; Zhongqiao Ren; Piyun Sun
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

3.  Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells.

Authors:  Emre Özgür; Ufuk Mert; Mustafa Isin; Murat Okutan; Nejat Dalay; Ugur Gezer
Journal:  Clin Exp Med       Date:  2012-04-10       Impact factor: 3.984

4.  Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor.

Authors:  Tomoshige Kino; Darrell E Hurt; Takamasa Ichijo; Nancy Nader; George P Chrousos
Journal:  Sci Signal       Date:  2010-02-02       Impact factor: 8.192

Review 5.  Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells.

Authors:  Mary Jo Atten; Ernesto Godoy-Romero; Bashar M Attar; Thomas Milson; Matthew Zopel; Oksana Holian
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

6.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

7.  MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles.

Authors:  Hongjae Sunwoo; Marcel E Dinger; Jeremy E Wilusz; Paulo P Amaral; John S Mattick; David L Spector
Journal:  Genome Res       Date:  2008-12-22       Impact factor: 9.043

8.  Identification and characterization of novel genotoxic stress-inducible nuclear long noncoding RNAs in mammalian cells.

Authors:  Rena Mizutani; Ai Wakamatsu; Noriyuki Tanaka; Hiroshi Yoshida; Naobumi Tochigi; Yoshio Suzuki; Tadahiro Oonishi; Hidenori Tani; Keiko Tano; Kenichi Ijiri; Takao Isogai; Nobuyoshi Akimitsu
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer.

Authors:  M Mourtada-Maarabouni; M R Pickard; V L Hedge; F Farzaneh; G T Williams
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  LncRNA loc285194 is a p53-regulated tumor suppressor.

Authors:  Qian Liu; Jianguo Huang; Nanjiang Zhou; Ziqiang Zhang; Ali Zhang; Zhaohui Lu; Fangting Wu; Yin-Yuan Mo
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

View more
  32 in total

1.  Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Authors:  David J Voce; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Wei Zhang; Nassir M Mansour; Kirk E Cahill; Szymon J Szymura; Abhineet Uppal; David R Raleigh; Ruben Spretz; Luis Nunez; Gustavo Larsen; Nikolai N Khodarev; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2019-04-02       Impact factor: 12.701

2.  NEAT1 regulates pancreatic cancer cell growth, invasion and migration though mircroRNA-335-5p/c-met axis.

Authors:  Jia Cao; Yi Zhang; Jiachun Yang; Sijia He; Mingming Li; Shiyan Yan; Ying Chen; Chunying Qu; Leiming Xu
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

Review 3.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

4.  Downregulation of the long non-coding RNA taurine-upregulated gene 1 inhibits glioma cell proliferation and invasion and promotes apoptosis.

Authors:  Zhijun Zhao; Bin Wang; Junhai Hao; Weitao Man; Yongkai Chang; Shunchang Ma; Yeshuai Hu; Fusheng Liu; Jun Yang
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

Review 5.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

6.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.

Authors:  H Cai; X Liu; J Zheng; Y Xue; J Ma; Z Li; Z Xi; Z Li; M Bao; Y Liu
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

7.  LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis.

Authors:  Jun Li; Meng Zhang; Gang An; Qingfang Ma
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-08

Review 8.  TUG1: a pivotal oncogenic long non-coding RNA of human cancers.

Authors:  Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-06-23       Impact factor: 6.831

9.  Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis.

Authors:  Xiaojie Chen; Jinyu Kong; Zhikun Ma; Shegan Gao; Xiaoshan Feng
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 10.  Exosomal noncoding RNAs: key players in glioblastoma drug resistance.

Authors:  Ahmad Movahedpour; Seyyed Hossein Khatami; Marjan Khorsand; Mahsa Salehi; Amir Savardashtaki; Seyedeh Habibeh Mirmajidi; Babak Negahdari; Nezhat Khanjani; Parisa Naeli; Omid Vakili; Mortaza Taheri-Anganeh
Journal:  Mol Cell Biochem       Date:  2021-07-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.